Search Clinical Trials in the European Union

Duration
Visits
Monitoring phase (IV)
Intake methods
Benefits
Drugs
Locations
Clinical Specialty
61-80 of 552 trials

Periodontitis: Vitamin D3 Supplementation Study

We are testing whether vitamin D3 can improve gum health in people with periodontitis and low vitamin D levels. This study will help us understand its effects alongside standard gum treatments.

Periodontitis6-12 monthsMonitoring phase (IV)≤5 visitsStandard MedicinesInternal MedicineOtolaryngology

Fibrotic Interstitial Lung Disease: Morphine for Breathlessness

We are studying whether slow-release morphine can help reduce breathlessness and cough in patients with fibrotic interstitial lung disease. The goal is to see if it improves their overall quality of life.

Fibrotic Interstitial Lung Disease≤3 monthsMonitoring phase (IV)≤5 visitsStandard MedicinesCost ReimbursementPartially RemotePulmonology

Dementia Care: Benefits of Amyloid PET Imaging

We are exploring how amyloid PET imaging may improve care for people with dementia compared to standard diagnostic methods. This study aims to show its impact on important health outcomes.

Dementia>2 yearsMonitoring phase (IV)6-10 visitsNo PlaceboStandard MedicinesPartially RemoteNeurologyPsychiatry

Parkinson's Disease: Safinamide vs. Rasagiline for Fatigue

We are studying whether Safinamide or Rasagiline can help reduce fatigue in people with Parkinson's Disease already on stable treatment. The trial will also monitor safety and side effects over six months.

Fatigue in Parkinson's Disease3-6 monthsMonitoring phase (IV)No PlaceboStandard MedicinesPartially RemoteNeurology

Elderly Surgery: Comparing Anesthesia Methods

We are studying how desflurane, sevoflurane, and propofol affect the risk of delirium and cognitive function in elderly patients after major abdominal surgery. This research aims to improve recovery outcomes for older adults undergoing surgery.

Postoperative Delirium>2 yearsConfirmation phase (III)Monitoring phase (IV)No PlaceboStandard MedicinesPartially Remote

Fludarabine in Stem Cell Transplantation

We are studying how Fludarabine exposure varies among patients receiving reduced intensity stem cell transplants. The goal is to understand its effects on long-term health and potential side effects.

Patients Undergoing Stem Cell Transplant for Blood Cancer>2 yearsMonitoring phase (IV)No PlaceboInvestigational MedicinesHematologyOncology

Personalized Anti-Platelet Therapy for Coronary Artery Disease

We are studying whether a genetic test-guided treatment improves blood platelet function in patients with stable coronary artery disease undergoing stenting. This may help determine the best anti-platelet therapy for individual patients.

Stable Coronary Artery DiseaseChronic Coronary Syndrome3-6 monthsMonitoring phase (IV)No PlaceboInvestigational MedicinesCardiologyInternal Medicine

Chronic Pancreatitis: Metamizole for Pain Relief

We are investigating whether adding metamizole to existing pain treatments helps reduce pain in patients with chronic pancreatitis diagnosed within the last three years.

Chronic Pancreatitis1-2 yearsMonitoring phase (IV)Standard MedicinesGastroenterologyInternal Medicine

Esophageal Cancer: Preventing Infections After Surgery

We are studying whether a special treatment can reduce the risk of pneumonia and other infections in patients undergoing surgery for esophageal cancer. This may help improve recovery and overall health after the procedure.

Esophageal Cancer3-6 monthsConfirmation phase (III)Monitoring phase (IV)No PlaceboInvestigational MedicinesGastroenterologyInfectious DiseasesOncologyPulmonology

Endometrial Cancer: NEPA for Nausea Relief

We are studying whether a single dose of NEPA can effectively prevent nausea and vomiting in patients with endometrial cancer receiving chemotherapy. This trial also assesses the safety of NEPA and its effects on patients' quality of life.

Chemotherapy-Induced Nausea and Vomiting Prophylaxis≤3 monthsMonitoring phase (IV)No PlaceboInvestigational MedicinesInternal MedicineOncology

Atopic Eczema: Dupilumab Dosing Study

We are studying how different dosing schedules of dupilumab affect people with controlled atopic eczema. The goal is to see which schedule works best for managing symptoms and improving quality of life.

Atopic Eczema3-6 monthsMonitoring phase (IV)≤5 visitsNo PlaceboStandard MedicinesPartially RemoteAllergologyDermatology

Fertility Treatment: Natural Progesterone vs. GnRH Antagonists

We are comparing a natural progesterone treatment to a standard injectable medication for women undergoing ovarian stimulation. The goal is to see which method is more effective and cost-efficient in preventing hormonal surges.

Women Undergoing Ovarian Stimulation for Oocyte DonationMonitoring phase (IV)No PlaceboInvestigational MedicinesGynecology and Obstetrics

Lumbar Spinal Surgery: Erector Spinae Plane Block

We are studying whether a specific pain management technique can reduce the need for morphine after lumbar spinal surgery. We will also look at recovery quality and any complications related to the procedure.

Patients Undergoing Lumbar ArthrodesisMonitoring phase (IV)No PlaceboStandard MedicinesInternal MedicineOrthopedics and TraumatologyOtolaryngology

Heart Procedure: Protamine Administration Study

We are comparing routine versus selective use of protamine during transcatheter aortic valve implantation to see which method better reduces bleeding and death risks after the procedure.

Aortic Stenosis≤3 monthsConfirmation phase (III)Monitoring phase (IV)Standard MedicinesCardiologyInternal Medicine

Diabetic Foot Ulcers: Plasma Rich in Growth Factors Treatment

We are studying whether Plasma Rich in Growth Factors can help heal foot ulcers in diabetic patients better than standard treatments. This trial aims to improve healing outcomes for those with peripheral arterial disease.

Foot Ulcers in Diabetic Patients3-6 monthsMonitoring phase (IV)≤5 visitsNo PlaceboInvestigational MedicinesDermatologyEndocrinology

Heart Disease Treatment: Drug-Coated Balloon vs. Drug-Eluting Stents

We are comparing a new balloon treatment with standard stents for patients with heart disease at high risk of bleeding. The goal is to see if the new method is just as effective while requiring less blood-thinning medication.

Coronary Artery Disease>2 yearsMonitoring phase (IV)No PlaceboInvestigational MedicinesCardiologyInternal Medicine

Pulmonary Arterial Hypertension: Triple Therapy Study

We are investigating whether a new combination of treatments, including an injectable medication, improves health outcomes for patients with pulmonary arterial hypertension. This study compares it to a standard oral treatment to see which is more effective.

Pulmonary Arterial Hypertension6-12 monthsConfirmation phase (III)Monitoring phase (IV)6-10 visitsNo PlaceboStandard MedicinesCost ReimbursementPartially RemoteCardiologyInternal Medicine

Non-ST Elevation Acute Coronary Syndrome: Aspirin Omission Study

We are investigating if avoiding aspirin can reduce bleeding risks for patients with non-ST segment elevation acute coronary syndrome. The goal is to see if this approach is as effective as current treatments for heart issues.

Non-ST-Segment Elevation Acute Coronary Syndrome>2 yearsMonitoring phase (IV)No PlaceboStandard MedicinesCost ReimbursementCardiologyInternal Medicine

Chronic Hepatitis D: Bulevirtide Treatment Study

We are studying the effects of Bulevirtide in patients with chronic hepatitis D to see how well it reduces the virus and improves liver health. This research will help us understand the treatment's safety and effectiveness over time.

Hepatitis DConfirmation phase (III)Monitoring phase (IV)No PlaceboStandard MedicinesHepatologyInfectious Diseases

Secukinumab: Long-Term Safety Study

We are evaluating the long-term safety of Secukinumab for patients who have previously participated in a related study. This trial will help us understand any potential side effects of continued treatment.

Psoriatic ArthritisAnkylosing SpondylitisNon-radiographic Axial Spondyloarthritis>2 yearsMonitoring phase (IV)>20 visitsPost-Trial Drug AccessNo PlaceboStandard MedicinesCost ReimbursementPartially RemoteDermatologyInternal MedicineRheumatology